News
Mathieu Roche discusses the role of identity in digital advertising performance, emphasizing transparent data collection and ...
The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.
Alainy Chiloh Roché is ready to tee up for a career in medicine or real estate development, but she will continue to improve ...
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than ...
Former club captain Barry Roche leaves Morecambe after 17 years at the Shrimps that spanned both playing and coaching roles.
From June 23 to 29, leading dermatological skincare brand La Roche-Posay will host a skin-focused pop-up activation at Ikeja City Mall, Lagos. The event will spotlight its Anthelios sun protection ...
The decision to advance prasinezumab to Phase III was based on results from the Phase IIb PADOVA trial, which demonstrated ...
Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...
The Swiss drugmaker said it was “encouraged” by the signs of effectiveness of the drug, developed by biotech Prothena, showed ...
Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...
Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...
Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results